Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · IEX Real-Time Price · USD
30.25
+1.15 (3.95%)
At close: Jul 19, 2024, 4:00 PM
30.29
+0.04 (0.13%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Supernus Pharmaceuticals Market Cap
Supernus Pharmaceuticals has a market cap or net worth of $1.66 billion as of July 22, 2024. Its market cap has increased by 3.37% in one year.
Market Cap
1.66B
Enterprise Value
1.40B
1-Year Change
3.37%
Ranking
Category
Stock Price
$30.25
Market Cap Chart
Since May 1, 2012, Supernus Pharmaceuticals's market cap has increased from $133.80M to $1.66B, an increase of 1,142.88%. That is a compound annual growth rate of 22.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 1.66B | 5.18% |
| Dec 29, 2023 | 1.58B | -18.01% |
| Dec 30, 2022 | 1.93B | 24.34% |
| Dec 31, 2021 | 1.55B | 16.99% |
| Dec 31, 2020 | 1.33B | 6.53% |
| Dec 31, 2019 | 1.24B | -28.32% |
| Dec 31, 2018 | 1.74B | -15.02% |
| Dec 29, 2017 | 2.04B | 63.41% |
| Dec 30, 2016 | 1.25B | 90.13% |
| Dec 31, 2015 | 657.50M | 84.54% |
| Dec 31, 2014 | 356.30M | 39.62% |
| Dec 31, 2013 | 255.20M | 45.08% |
| Dec 31, 2012 | 175.90M | 31.46% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Keros Therapeutics | 1.75B |
| Galapagos NV | 1.72B |
| Soleno Therapeutics | 1.71B |
| NewAmsterdam Pharma Company | 1.70B |
| Evotec SE | 1.67B |
| Kura Oncology | 1.60B |
| Avadel Pharmaceuticals | 1.56B |
| MannKind | 1.55B |